from an infected person to household members by 32% 1 CENTERSTONE is the first global phase III trial that demonstrates the benefit of an antiviral in reducing the spread of a respiratory virus 1 ...

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the primary goal of significantly reducing A1C levels compared to placebo at ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of influenza virus, from an infected person to household members by 32% – – ...

III Points is returning to Miami, Florida, this October with another excitingly diverse array of performers. The “phase one” lineup for the music festival includes hardcore (Turnstile), rap ...

After a number of Phase III successes in China, Summit is launching a multi-regional trial as the race for approval in the US and elsewhere across the globe begins. Image credit: Shutterstock / Tuhaa ...

Credit: JHVEPhoto/Shutterstock. Gilead Sciences has reported positive topline data from the randomised Phase III ASCENT-04/KEYNOTE-D19 trial of Trodelvy (sacituzumab govitecan-hziy) and MSD’s Keytruda ...

President Donald Trump in February threatened top pharma leaders, including Eli Lilly CEO David Ricks, with tariffs unless they reshore their manufacturing operations. Eli Lilly will produce its ...

AstraZeneca said that when used in conjunction with pertuzumab, Enhertu had demonstrated a "highly statistically significant and clinically meaningful improvement" in progression-free survival ...